Connection

Narendra Vyavahare to Calcinosis

This is a "connection" page, showing publications Narendra Vyavahare has written about Calcinosis.
Connection Strength

3.507
  1. Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects. J Control Release. 2014 Dec 28; 196:79-86.
    View in: PubMed
    Score: 0.424
  2. Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves. J Biomed Mater Res B Appl Biomater. 2010 Jan; 92(1):168-77.
    View in: PubMed
    Score: 0.305
  3. Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. Cardiovasc Pathol. 2007 Jan-Feb; 16(1):29-37.
    View in: PubMed
    Score: 0.247
  4. Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. Am J Pathol. 2006 Feb; 168(2):490-8.
    View in: PubMed
    Score: 0.232
  5. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials. 2005 Apr; 26(11):1237-45.
    View in: PubMed
    Score: 0.219
  6. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 2004 Nov 30; 110(22):3480-7.
    View in: PubMed
    Score: 0.213
  7. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Cardiovasc Pathol. 2004 May-Jun; 13(3):146-55.
    View in: PubMed
    Score: 0.206
  8. Role of elastin in pathologic calcification of xenograft heart valves. J Biomed Mater Res A. 2003 Jul 01; 66(1):93-102.
    View in: PubMed
    Score: 0.194
  9. Aluminum chloride pretreatment of elastin inhibits elastolysis by matrix metalloproteinases and leads to inhibition of elastin-oriented calcification. Am J Pathol. 2001 Dec; 159(6):1981-6.
    View in: PubMed
    Score: 0.174
  10. Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats. Am J Pathol. 2000 Sep; 157(3):885-93.
    View in: PubMed
    Score: 0.159
  11. Elastin calcification and its prevention with aluminum chloride pretreatment. Am J Pathol. 1999 Sep; 155(3):973-82.
    View in: PubMed
    Score: 0.149
  12. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res. 1998 Jun 15; 40(4):577-85.
    View in: PubMed
    Score: 0.137
  13. Fixation of Bovine Pericardium-Based Tissue Biomaterial with Irreversible Chemistry Improves Biochemical and Biomechanical Properties. J Cardiovasc Transl Res. 2017 Apr; 10(2):194-205.
    View in: PubMed
    Score: 0.125
  14. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation. 1997 Jan 21; 95(2):479-88.
    View in: PubMed
    Score: 0.124
  15. Neomycin and pentagalloyl glucose enhanced cross-linking for elastin and glycosaminoglycans preservation in bioprosthetic heart valves. J Biomater Appl. 2014 Jan; 28(5):757-66.
    View in: PubMed
    Score: 0.100
  16. Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves. J Biomater Appl. 2013 May; 27(8):948-60.
    View in: PubMed
    Score: 0.087
  17. In vivo vascular tissue engineering: influence of cytokine and implant location on tissue specific cellular recruitment. J Tissue Eng Regen Med. 2009 Jun; 3(4):280-9.
    View in: PubMed
    Score: 0.073
  18. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation. 2007 Apr 03; 115(13):1729-37.
    View in: PubMed
    Score: 0.063
  19. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials. 2006 Mar; 27(8):1507-18.
    View in: PubMed
    Score: 0.056
  20. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism. J Heart Valve Dis. 2003 Mar; 12(2):209-16; discussion 216.
    View in: PubMed
    Score: 0.047
  21. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis. 2003 Mar; 12(2):217-25.
    View in: PubMed
    Score: 0.047
  22. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies. J Heart Valve Dis. 2000 Jul; 9(4):561-6.
    View in: PubMed
    Score: 0.039
  23. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis. 1999 May; 8(3):254-60.
    View in: PubMed
    Score: 0.036
  24. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res. 1998 Oct; 42(1):30-7.
    View in: PubMed
    Score: 0.035
  25. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms. Am J Pathol. 2005 Jan; 166(1):1-13.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.